LINC01133 and pancreatic adenocarcinoma: Another multi-omics study (Fig. 4c) [35] and two GEO databases, GSE16515 (Fig. 4d) and GSE32676 (Fig. 4e), demonstrated the overexpression of LINC01133 in PAAD.